
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $23.3B | $42.1B | $57.3B | $48.7B | $50.1B | |
Revenue Growth (YoY) | -30.83% | 80.67% | 36.28% | -15.05% | 2.79% | |
Cost of Revenues | $22.2B | $40.3B | $55.5B | $47B | $48.4B | |
Gross Profit | $1.1B | $1.7B | $1.9B | $1.7B | $1.7B | |
Gross Profit Margin | 4.85% | 4.12% | 3.29% | 3.51% | 3.43% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $271M | $292M | $325M | $350M | $381M | |
Other Inc / (Exp) | -$3B | -$297M | $261M | $624M | $302M | |
Operating Expenses | $271M | $292M | $325M | $350M | $381M | |
Operating Income | $859M | $1.4B | $1.6B | $1.4B | $1.3B | |
Net Interest Expenses | $436M | $425M | $405M | $359M | $360M | |
EBT. Incl. Unusual Items | -$2.6B | $721M | $1.4B | $1.6B | $1.3B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$19M | $73M | $189M | $121M | $167M | |
Net Income to Company | -$2.6B | $648M | $1.2B | $1.5B | $1.1B | |
Minority Interest in Earnings | -$10M | -$55M | -$191M | -$272M | -$341M | |
Net Income to Common Excl Extra Items | -$2.6B | $593M | $1B | $1.2B | $772M | |
Basic EPS (Cont. Ops) | -$3.83 | $0.55 | $1.19 | $1.40 | $0.73 | |
Diluted EPS (Cont. Ops) | -$3.83 | $0.55 | $1.19 | $1.40 | $0.73 | |
Weighted Average Basic Share | $728M | $716M | $701M | $699M | $702M | |
Weighted Average Diluted Share | $728M | $716M | $701M | $699M | $702M | |
EBITDA | -$1.5B | $1.9B | $2.8B | $3.1B | $2.7B | |
EBIT | -$2.2B | $1.1B | $1.8B | $2B | $1.7B | |
Revenue (Reported) | $23.3B | $42.1B | $57.3B | $48.7B | $50.1B | |
Operating Income (Reported) | $859M | $1.4B | $1.6B | $1.4B | $1.3B | |
Operating Income (Adjusted) | -$2.2B | $1.1B | $1.8B | $2B | $1.7B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $8.4B | $13.7B | $12.3B | $12B | $12B | |
Revenue Growth (YoY) | 1.38% | 63.35% | -9.88% | -2.8% | 0.13% | |
Cost of Revenues | $7.8B | $13.4B | $11.9B | $11.5B | $11.4B | |
Gross Profit | $595M | $333M | $405M | $466M | $620M | |
Gross Profit Margin | 7.1% | 2.43% | 3.28% | 3.89% | 5.16% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $67M | $82M | $86M | $96M | $100M | |
Other Inc / (Exp) | $26M | $102M | $307M | $85M | $148M | |
Operating Expenses | $67M | $82M | $86M | $96M | $100M | |
Operating Income | $528M | $251M | $319M | $370M | $520M | |
Net Interest Expenses | $107M | $107M | $98M | $90M | $102M | |
EBT. Incl. Unusual Items | $447M | $246M | $528M | $365M | $566M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $24M | $21M | $53M | $14M | $50M | |
Net Income to Company | $423M | $225M | $475M | $351M | $516M | |
Minority Interest in Earnings | -$1M | -$38M | -$53M | -$85M | -$73M | |
Net Income to Common Excl Extra Items | $422M | $187M | $422M | $266M | $443M | |
Basic EPS (Cont. Ops) | $0.51 | $0.19 | $0.52 | $0.29 | $0.49 | |
Diluted EPS (Cont. Ops) | $0.51 | $0.19 | $0.52 | $0.29 | $0.49 | |
Weighted Average Basic Share | $722M | $705M | $698M | $701M | $704M | |
Weighted Average Diluted Share | $722M | $705M | $698M | $701M | $704M | |
EBITDA | $731M | $583M | $882M | $714M | $955M | |
EBIT | $554M | $353M | $626M | $460M | $693M | |
Revenue (Reported) | $8.4B | $13.7B | $12.3B | $12B | $12B | |
Operating Income (Reported) | $528M | $251M | $319M | $370M | $520M | |
Operating Income (Adjusted) | $554M | $353M | $626M | $460M | $693M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $23.4B | $47.4B | $56B | $48.4B | $50.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $22.1B | $45.9B | $54B | $46.6B | $48.2B | |
Gross Profit | $1.3B | $1.5B | $2B | $1.8B | $1.9B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $270M | $308M | $329M | $360M | $385M | |
Other Inc / (Exp) | $81M | -$220M | $465M | $408M | $363M | |
Operating Expenses | $270M | $308M | $329M | $360M | $385M | |
Operating Income | $1B | $1.2B | $1.6B | $1.4B | $1.5B | |
Net Interest Expenses | $435M | $426M | $396M | $357M | $373M | |
EBT. Incl. Unusual Items | $671M | $520M | $1.7B | $1.5B | $1.5B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$17M | $70M | $221M | $82M | $202M | |
Net Income to Company | $688M | $450M | $1.5B | $1.4B | $1.3B | |
Minority Interest in Earnings | -$9M | -$92M | -$206M | -$304M | -$329M | |
Net Income to Common Excl Extra Items | $679M | $358M | $1.3B | $1.1B | $949M | |
Basic EPS (Cont. Ops) | $0.66 | $0.23 | $1.52 | $1.17 | $0.93 | |
Diluted EPS (Cont. Ops) | $0.66 | $0.23 | $1.52 | $1.17 | $0.93 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.8B | $1.8B | $3.1B | $2.9B | $3B | |
EBIT | $1.1B | $946M | $2.1B | $1.8B | $1.9B | |
Revenue (Reported) | $23.4B | $47.4B | $56B | $48.4B | $50.1B | |
Operating Income (Reported) | $1B | $1.2B | $1.6B | $1.4B | $1.5B | |
Operating Income (Adjusted) | $1.1B | $946M | $2.1B | $1.8B | $1.9B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $8.4B | $13.7B | $12.3B | $12B | $12B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $7.8B | $13.4B | $11.9B | $11.5B | $11.4B | |
Gross Profit | $595M | $333M | $405M | $466M | $620M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $67M | $82M | $86M | $96M | $100M | |
Other Inc / (Exp) | $26M | $102M | $307M | $85M | $148M | |
Operating Expenses | $67M | $82M | $86M | $96M | $100M | |
Operating Income | $528M | $251M | $319M | $370M | $520M | |
Net Interest Expenses | $107M | $107M | $98M | $90M | $102M | |
EBT. Incl. Unusual Items | $447M | $246M | $528M | $365M | $566M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $24M | $21M | $53M | $14M | $50M | |
Net Income to Company | $423M | $225M | $475M | $351M | $516M | |
Minority Interest in Earnings | -$1M | -$38M | -$53M | -$85M | -$73M | |
Net Income to Common Excl Extra Items | $422M | $187M | $422M | $266M | $443M | |
Basic EPS (Cont. Ops) | $0.51 | $0.19 | $0.52 | $0.29 | $0.49 | |
Diluted EPS (Cont. Ops) | $0.51 | $0.19 | $0.52 | $0.29 | $0.49 | |
Weighted Average Basic Share | $722M | $705M | $698M | $701M | $704M | |
Weighted Average Diluted Share | $722M | $705M | $698M | $701M | $704M | |
EBITDA | $731M | $583M | $882M | $714M | $955M | |
EBIT | $554M | $353M | $626M | $460M | $693M | |
Revenue (Reported) | $8.4B | $13.7B | $12.3B | $12B | $12B | |
Operating Income (Reported) | $528M | $251M | $319M | $370M | $520M | |
Operating Income (Adjusted) | $554M | $353M | $626M | $460M | $693M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $22M | $449M | $401M | $450M | $348M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $2.6B | $4.7B | $3.9B | $3.8B | $3.9B | |
Inventory | $647M | $783M | $729M | $548M | $439M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $405M | $200M | $318M | $155M | $114M | |
Total Current Assets | $3.7B | $6.1B | $5.4B | $4.9B | $4.8B | |
Property Plant And Equipment | $15B | $15.3B | $15.6B | $16.1B | $15.8B | |
Long-Term Investments | $3.8B | $3.8B | $3.1B | $2.8B | $2.8B | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | $805M | $2B | $2.1B | $1.9B | $1.7B | |
Other Long-Term Assets | $1.3B | $1.4B | $1.7B | $1.7B | $1.5B | |
Total Assets | $24.5B | $28.6B | $27.9B | $27.4B | $26.6B | |
Accounts Payable | $2.4B | $4.8B | $4B | $3.8B | $3.9B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | $117M | $822M | $1.2B | $13M | $15M | |
Current Portion Of Capital Lease Obligations | $78M | $77M | -- | -- | -- | |
Other Current Liabilities | $907M | $523M | $688M | $713M | $661M | |
Total Current Liabilities | $4.3B | $6.2B | $5.9B | $5B | $5B | |
Long-Term Debt | $9.3B | $8.4B | $7.3B | $7.3B | $7.2B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $14.8B | $15.8B | $14.6B | $13.6B | $13.5B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $9.6B | $10B | $10.1B | $10.4B | $9.8B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $145M | $2.8B | $3.3B | $3.3B | $3.3B | |
Total Equity | $9.7B | $12.8B | $13.3B | $13.7B | $13.1B | |
Total Liabilities and Equity | $24.5B | $28.6B | $27.9B | $27.4B | $26.6B | |
Cash and Short Terms | $22M | $449M | $401M | $450M | $348M | |
Total Debt | $10.1B | $9.2B | $8.4B | $7.8B | $7.6B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $30M | $114M | $526M | $331M | $427M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $3.4B | $7.1B | $4B | $4B | $3.8B | |
Inventory | $484M | $527M | $463M | $453M | $335M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $483M | $320M | $165M | $177M | $153M | |
Total Current Assets | $4.4B | $8.1B | $5.1B | $5B | $4.7B | |
Property Plant And Equipment | $14.9B | $15.3B | $15.5B | $16B | $16.4B | |
Long-Term Investments | $3.8B | $3.8B | $3.1B | $2.9B | $2.7B | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $2.2B | $1.6B | $1.6B | $1.7B | $1.5B | |
Total Assets | $25.3B | $30.6B | $27.5B | $27.4B | $27.1B | |
Accounts Payable | $3.4B | $6.9B | $4B | $4B | $3.7B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | $117M | $518M | $708M | $14M | $14M | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $1B | $803M | $649M | $599M | $488M | |
Total Current Liabilities | $4.7B | $8.6B | $5.4B | $5.1B | $4.7B | |
Long-Term Debt | $9.3B | $8B | $7.3B | $7.3B | $8.2B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $15.2B | $17.8B | $14B | $13.7B | $14.2B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -$333M | |
Minority Interest, Total | $141M | $2.8B | $3.2B | $3.3B | $3.2B | |
Total Equity | $10.1B | $12.9B | $13.5B | $13.6B | $12.9B | |
Total Liabilities and Equity | $25.3B | $30.6B | $27.5B | $27.4B | $27.1B | |
Cash and Short Terms | $30M | $114M | $526M | $331M | $427M | |
Total Debt | $9.6B | $8.9B | $8B | $7.9B | $8.7B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$2.6B | $648M | $1.2B | $1.5B | $1.1B | |
Depreciation & Amoritzation | $653M | $774M | $965M | $1B | $1B | |
Stock-Based Compensation | $15M | $23M | $40M | $50M | $50M | |
Change in Accounts Receivable | $1.4B | -$2.2B | $649M | $213M | $94M | |
Change in Inventories | -$304M | -$18M | -$10M | $223M | $70M | |
Cash From Operations | $1.5B | $2B | $2.4B | $2.7B | $2.5B | |
Capital Expenditures | $738M | $336M | $455M | $559M | $619M | |
Cash Acquisitions | -$771M | -$126M | -$163M | -$458M | -$252M | |
Cash From Investing | -$1.1B | $386M | -$526M | -$702M | -$1.5B | |
Dividends Paid (Ex Special Dividend) | -$853M | -$715M | -$782M | -$989M | -$1.1B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $748M | -- | -- | -- | $1.3B | |
Long-Term Debt Repaid | -$617M | -$367M | -$750M | -$1.1B | -$750M | |
Repurchase of Common Stock | -$50M | -$178M | -$74M | -- | -- | |
Other Financing Activities | $41M | -$179M | -$325M | -$320M | -$421M | |
Cash From Financing | -$435M | -$2B | -$1.9B | -$2B | -$1.1B | |
Beginning Cash (CF) | $82M | $60M | $453M | $401M | $450M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$14M | $398M | -$49M | $49M | -$91M | |
Ending Cash (CF) | $60M | $453M | $401M | $450M | $348M | |
Levered Free Cash Flow | $776M | $1.7B | $2B | $2.2B | $1.9B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$216M | $251M | $349M | $330M | -- | |
Depreciation & Amoritzation | $197M | $243M | $259M | $257M | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $235M | $792M | $888M | $653M | -- | |
Capital Expenditures | $85M | $89M | $145M | $139M | -- | |
Cash Acquisitions | -$68M | -$1M | -$15M | -$20M | -- | |
Cash From Investing | -$175M | -$42M | -$164M | -$157M | -- | |
Dividends Paid (Ex Special Dividend) | -$192M | -$215M | -$247M | -$285M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $115M | -- | $543M | -- | |
Long-Term Debt Repaid | -$160M | -- | -- | -$433M | -- | |
Repurchase of Common Stock | -$50M | -$49M | -- | -- | -- | |
Other Financing Activities | -$95M | -$68M | -$78M | -$97M | -- | |
Cash From Financing | -$87M | -$599M | -$325M | -$272M | -- | |
Beginning Cash (CF) | $56M | $118M | $526M | $331M | -- | |
Foreign Exchange Rate Adjustment | $2M | -$2M | $8M | -$2M | -- | |
Additions / Reductions | -$27M | $151M | $399M | $224M | -- | |
Ending Cash (CF) | $31M | $267M | $933M | $553M | -- | |
Levered Free Cash Flow | $150M | $703M | $743M | $514M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $688M | $450M | $1.5B | $1.4B | $1.3B | |
Depreciation & Amoritzation | $662M | $827M | $991M | $1B | $1B | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1.4B | $1.5B | $2.8B | $2.4B | $2.7B | |
Capital Expenditures | $590M | $340M | $476M | $594M | $653M | |
Cash Acquisitions | -$351M | -$94M | -$164M | -$548M | -$782M | |
Cash From Investing | -$591M | $413M | -$287M | -$1.1B | -$2.4B | |
Dividends Paid (Ex Special Dividend) | -$721M | -$712M | -$860M | -$1B | -$1.2B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $107M | $2.6B | |
Long-Term Debt Repaid | -$690M | -$951M | -$400M | -$700M | -- | |
Repurchase of Common Stock | -$53M | -$200M | -- | -- | -- | |
Other Financing Activities | -$11M | -$278M | -$419M | -$279M | -$473M | |
Cash From Financing | -$930M | -$1.9B | -$2.1B | -$1.5B | -$214M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$106M | $64M | $414M | -$191M | $104M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $825M | $1.2B | $2.3B | $1.8B | $2.1B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $207M | $476M | $824M | $681M | $516M | |
Depreciation & Amoritzation | $374M | $473M | $515M | $511M | $262M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1B | $1.1B | $1.6B | $1.1B | $639M | |
Capital Expenditures | $182M | $190M | $267M | $296M | $191M | |
Cash Acquisitions | -$103M | -$4M | -$19M | -$114M | -$624M | |
Cash From Investing | -$283M | -$123M | -$6M | -$418M | -$1.1B | |
Dividends Paid (Ex Special Dividend) | -$359M | -$379M | -$489M | -$572M | -$331M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $115M | -- | $650M | $1.4B | |
Long-Term Debt Repaid | -$326M | -$750M | -$400M | -$433M | -- | |
Repurchase of Common Stock | -$53M | -$74M | -- | -- | -$333M | |
Other Financing Activities | -$36M | -$108M | -$212M | -$190M | -$145M | |
Cash From Financing | -$774M | -$1.2B | -$1.1B | -$545M | $590M | |
Beginning Cash (CF) | $116M | $571M | $927M | $781M | $348M | |
Foreign Exchange Rate Adjustment | $2M | $1M | $8M | -$6M | -$1M | |
Additions / Reductions | -$31M | -$187M | $524M | $109M | $80M | |
Ending Cash (CF) | $87M | $385M | $1.5B | $884M | $427M | |
Levered Free Cash Flow | $844M | $942M | $1.4B | $776M | $448M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.